Desensitization of an adult patient with Pompe disease and a history of anaphylaxis to alglucosidase alfa

被引：23

作者：

Lipinski, Shawn E. ^{[1
]}

Lipinski, Michael J. ^{[2
]}

Burnette, Autumn ^{[3
]}

Platts-Mills, Thomas A. ^{[3
]}

Wilson, William G. ^{[1
]}

机构：

[1] Univ Virginia Hlth Syst, Dept Pediat, Div Med Genet, Charlottesville, VA 22908 USA

[2] Univ Virginia Hlth Syst, Dept Internal Med, Charlottesville, VA 22908 USA

[3] Univ Virginia Hlth Syst, Asthma & Allerg Dis Ctr, Charlottesville, VA 22908 USA

来源：

MOLECULAR GENETICS AND METABOLISM | 2009年 / 98卷 / 03期

关键词：

Pompe disease; Enzyme replacement therapy; Lysosomal storage disease; Anaphylaxis; Allergy;

D O I：

10.1016/j.ymgme.2009.07.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report on the successful desensitization of an adult female with Pompe disease who had previously experienced anaphylaxis to intravenous alglucosidase alfa therapy. The starting alglucosidase alfa dose for desensitization was 10 mg/kg with gradual dose escalation and desensitization via serial dilution was completed over five infusions. This methodology serves as a means to desensitize patients with prior anaphylactic response to alglucosidase alfa so that enzyme replacement therapy can be utilized. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：319 / 321

页数：3

共 50 条

[1] DESENSITIZATION OF AN INFANT WITH POMPE DISEASE AND A HISTORY OF ANAPHYLAXIS TO ALGLUCOSIDASE ALFA
Kucukcongar, A.
Karagol, Ertog, I
Ezgu, F. S.
Tumer, L.
Kasapkara, C. S.
Hasanoglu, A.
[J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S108 - S108
[2] Long-Term Experience with Anaphylaxis and Desensitization to Alglucosidase Alfa in Pompe Disease
Karagol, Hacer Ilbilge Ertoy
Inci, Asli
Terece, Sinem Polat
Kilic, Ayse
Demir, Fevzi
Yapar, Dilek
Koken, Gizem
Okur, Ilyas
Ezgu, Fatih Suheyl
Tumer, Leyla
Bakirtas, Arzu
[J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2023, 184 (04) : 370 - 375
[3] Desensitization in a patient with Pompe disease and a history of anaphylaxis to myozyme
Ford, A.
Lipinski, S. E.
Wilson, W. G.
Adkinson, N. F.
Platts-Mills, T. A.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A63 - A63
[4] Desensitisation of the youngest patient with Pompe disease in response to alglucosidase alfa
Karagol, I. H. E.
Bakirtas, A.
Yilmaz, O.
Topal, E.
Kucukcongar, A.
Ezgu, F. S.
Demirsoy, M. S.
Turktas, I.
[J]. ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (04) : 372 - 375
[5] BLA filed for alglucosidase alfa in Pompe disease
不详
[J]. DRUG NEWS & PERSPECTIVES, 2005, 18 (06) : 374 - 374
[6] ALGLUCOSIDASE ALFA IN INFANTS AND CHILDREN WITH POMPE DISEASE
Kishnani, P.
Hwu, W. -L.
Leslie, N.
Wraith, J.
Nicolino, M.
[J]. CLINICAL THERAPEUTICS, 2008, 30 : S114 - S114
[7] Alglucosidase alfa in infants and children with Pompe disease
Wraith, E.
Byrne, B.
Hwu, W. L.
Leslie, N.
Mandel, H.
Nicolino, M.
Kishnani, P. S.
[J]. NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 800 - 800
[8] High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
de Vries, Juna M.
van der Beek, Nadine A. M. E.
Kroos, Marian A.
Ozkan, Lale
van Doorn, Pieter A.
Richards, Susan M.
Sung, Crystal C. C.
Brugma, Jan-Dietert C.
Zandbergen, Adrienne A. M.
van der Ploeg, Ans T.
Reuser, Arnold J. J.
[J]. MOLECULAR GENETICS AND METABOLISM, 2010, 101 (04) : 338 - 345
[9] Profile of alglucosidase alfa in the treatment of Pompe disease: safety, efficacy, and patient acceptability
Schneider, Ilka
Zierz, Stephan
[J]. RESEARCH AND REPORTS IN ENDOCRINE DISORDERS, 2016, 6 : 1 - 16
[10] Alglucosidase alfa and Pompe disease: Still going strong?
Lipinski, Shawn E.
[J]. MOLECULAR GENETICS AND METABOLISM, 2012, 107 (03) : 245 - 246

← 1 2 3 4 5 →